← Human Trials & Peer-Reviewed Studies
A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children.
Plain-language guide to PMID 10451461 (1999): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 123 children.
Key Facts
- PMID
- 10451461
- Journal
- The New England journal of medicine
- Year
- 1999
- Study type
- Randomized Controlled Trial
- Authors
- Thacher TD et al. (7 authors)
- DOI
- 10.1056/NEJM199908193410803
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
The researchers measured serum calcium and alkaline phosphatase and used a 10-point radiographic score to assess the response to treatment at 24 weeks.
Why It Was Studied
Nutritional rickets remains prevalent in many tropical countries despite the fact that such countries have ample sunlight.
Some postulate that a deficiency of dietary calcium, rather than vitamin D, is often responsible for rickets after infancy.
Who Took Part
The abstract describes 123 children taking part.
By PubMed's age tags, the people studied were young children, both men and women.
The researchers compared the calcium intake of the children at enrollment with that of control children without rickets who were matched for sex, age, and weight.
How the Study Was Run
In design terms this was a randomized and double-blind study.
The children were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Blinding on both sides kept the children and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
What Was Measured
The subject headings attached to it are Alkaline Phosphatase, Calcium, Calcium, Dietary, Nigeria, Rickets and Vitamin D.
The authors tagged it with the keywords Africa, Africa South Of The Sahara, Age Factors, Biology, Child and Comparative Studies.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 123 children.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 1999 (The New England journal of medicine), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.